Similar articles

• T-helper lymphocytes and syngeneic graft-versus-host disease.

  Bos GM, Majoor GD, van de Gaar MJ, van Breda Vriesman PJ. Bos GM, et al. Transplant Proc. 1989 Feb;21(1 Pt 3):3016-7. Transplant Proc. 1989. PMID: 2523170 No abstract available.
• Syngeneic graft-versus-host disease: a report of two cases and literature review.

  Latif T, Pohlman B, Kalaycio M, Sobecks R, Hsi ED, Andresen S, Bolwell BJ. Latif T, et al. Bone Marrow Transplant. 2003 Sep;32(5):535-9. doi: 10.1038/sj.bmt.1704171. Bone Marrow Transplant. 2003. PMID: 12942102 Review.
• Similarity of scleroderma-like skin lesions in allogeneic and syngeneic bone marrow transplantation models.

  Bos GM, Majoor GD, Slaaf DW, van de Gaar MJ, Weijmer-van Velzen JS, van Breda Vriesman PJ. Bos GM, et al. Transplant Proc. 1989 Apr;21(2):3262-3. Transplant Proc. 1989. PMID: 2652812 No abstract available.
• Induction of autologous graft-versus-host disease.

  Vogelsang GB, Jones RJ, Hess AD, Geller R, Schucter L, Santos GW. Vogelsang GB, et al. Transplant Proc. 1989 Feb;21(1 Pt 3):2997-8. Transplant Proc. 1989. PMID: 2650411 No abstract available.
• Autologous graft-vs-host disease: mechanisms and potential therapeutic effect.

  Hess AD, Jones RC, Santos GW. Hess AD, et al. Bone Marrow Transplant. 1993;12 Suppl 3:S65-9. Bone Marrow Transplant. 1993. PMID: 8124261 Review.